The goal of the study is to define the safety and tolerability of oral alendronate when administered for one year in glucocorticoid-treated patients. The study will also assess the effect of oral alendronate on spinal bone mineral in patients treated with oral prednisone.
Showing the most recent 10 out of 381 publications